Premium
P3‐272: Differentiating Preclinical Alzheimer’S Disease From Normal Aging: the Effects of age and Amyloid on Cognitive Decline Over 3.5 Years
Author(s) -
Farrell Michelle E.,
Kennedy Kristen M.,
Rodrigue Karen M.,
Wig Gagan S.,
Bischof Gérard N.,
Rieck Jennifer R.,
Chen Xi,
Festini Sara B.,
Devous Michael D.,
Park Denise C.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.1935
Subject(s) - episodic memory , cognitive decline , amyloid (mycology) , cognition , psychology , alzheimer's disease , medicine , longitudinal study , gerontology , disease , dementia , pathology , neuroscience
P3-272 DIFFERENTIATING PRECLINICAL ALZHEIMER’S DISEASE FROM NORMAL AGING: THE EFFECTS OFAGE AND AMYLOID ON COGNITIVE DECLINE OVER 3.5 YEARS Michelle E. Farrell, Kristen M. Kennedy, Karen M. Rodrigue, Gagan S. Wig, G erard N. Bischof, Jennifer R. Rieck, Xi Chen, Sara B. Festini, Michael D. Devous, Sr., Denise C. Park, University of Texas at Dallas, Dallas, TX, USA; 2 Institute of Neuroscience and Medicine, J€ulich, Germany; 3 University Hospital Cologne, Cologne, Germany; 4 Avid Radiopharmaceuticals, Philadelphia, PA, USA. Contact e-mail: michelle. farrell1@utdallas.edu